Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
01/27 3SBIO : to add stake in CP Guojian Pharmaceutical
01/20 3SBIO : to add stake in CP Guojian
01/05DJChinese Drugmaker Plans up to $3 Billion Hong Kong IPO
SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD531993Chairman, President & Chief Executive Officer
Bo Tan, MBA432009Chief Financial Officer, Executive Director & EVP
Yong Fu Chen582011Director-Financial Department
Dong Mei Su, PhD462012Director & Chief Technology Officer
Bin Huang, MBA551993Executive Director & VP-Human Resources
Dong Liu, MBA432014Non-Executive Director
Dong LV, PhD412014Non-Executive Director
Tian Ruo Pu, MBA482014Independent Non-Executive Director
David R. Parkinson MD, PhD652014Independent Non-Executive Director
Jun Ma, PhD522014Independent Non-Executive Director
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.3%
Jing Lou, MD, PhD 599,367,030 23.8%
Bo Tai 115,549,920 4.59%
Dan Lou 62,001,010 2.46%
HSBC Global Asset Management (Hong Kong) Ltd. 38,385,500 1.53%
Bin Huang, MBA 33,919,350 1.35%
BlackRock Asset Management North Asia Ltd. 27,310,378 1.09%
Dong Mei Su, PhD 26,403,630 1.05%
Allianz Global Investors Asia Pacific Ltd. 16,157,500 0.64%
The Vanguard Group, Inc. 8,321,000 0.33%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
CELGENE CORPORATI..
REGENERON PHARMAC..
VERTEX PHARMACEUT..
SHANGHAI RAAS BLO..
-
ACTELION LTD
GENMAB A/S
MEDIVATION INC
TONGHUA DONGBAO P..
HUALAN BIOLOGICAL..
NEUROCRINE BIOSCI..
JUNO THERAPEUTICS..
INTERCEPT PHARMAC..
3SBIO INC
-
CHINA BIOLOGIC PR..
BEIJING SL PHARMA..
ZHONGYUAN UNION C..
ULTRAGENYX PHARMA..
-
KITE PHARMA INC
Sector Biotechnology & Medical Research
3SBio Inc. (ADR) : Connections
Collected Mind Ltd.
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Excel Partner Holdings Ltd.
Zyngenia, Inc.
UTStarcom, Inc.
Hongkong Sansheng Medical Ltd.
Ample Harvest Investments Ltd.
Beingmate Group Co. Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Hong Kong Sansheng Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Ontario Institute for Cancer Research
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Tocagen, Inc.
Liaoning Sunshine Science & Technology Development Co. Ltd.
CFA Institute
The Multiple Myeloma Research Foundation, Inc.
Shenyang Sunshine Pharmaceutical Co. Ltd.
Multiple Myeloma Research Consortium
Company contact information
3SBio, Inc.
Shenyang Economy & Technology Dev
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.2538.6000
Fax : +86.24.2581.1821
Web : www.3sbio.com
© 2016 People , Fundamentals and Ownership